Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Collaboration Revenue $ 16,000,000 $ 0
Total Revenue 16,000,000 0
Operating Expenses:    
General and Administrative 1,296,441 1,269,458
Research and Development 1,493,659 438,283
Change in Fair Value of Contingent Consideration (12,194) 208,926
Total Operating Expenses 2,777,906 1,916,667
Operating Income (Loss) 13,222,094 (1,916,667)
Other Income, Net:    
Interest Income, Net 223,047 33,465
Other Income, Net 8,066 14,666
Total Other Income, Net 231,113 48,131
Net Income (Loss) $ 13,453,207 $ (1,868,536)
Net Loss per Common Share - Basic (in usd per share) $ 0.52 $ (1.00)
Weighted Average Shares Outstanding - Basic (in shares) 25,936,163 1,863,466
Net Loss per Common Share - Diluted (in usd per share) $ 0.38 $ (1.00)
Weighted Average Shares Outstanding - Diluted (in shares) 35,025,494 1,863,466
Other Comprehensive Income (Loss):    
Net Income (Loss) $ 13,453,207 $ (1,868,536)
Foreign Currency Translation Adjustments (81,573) (32,671)
Comprehensive Income (Loss) $ 13,371,634 $ (1,901,207)